Recent trends and special topics in new drug review in PMDA

Journal Title: Generics and Biosimilars Initiative Journal - Year 2013, Vol 2, Issue 2

Abstract

The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory agency, which works together with the Ministry of Health, Labour and Welfare. At the 24th Drug Information Association Annual EuroMeeting in March 2012, PMDA presented an overview of recent trends and special topics in new drug review. Here, the current status and trends are highlighted, and the new drug review is discussed.

Authors and Affiliations

Toshiki Sugita

Keywords

Related Articles

New CHMP guideline on immunogenicity of monoclonal antibodies

The importance of monoclonal antibodies as a product class and the challenge of assessing unwanted immunogenicity for these products have prompted the drafting of a new CHMP (Committee for Medicinal Products for Human Us...

Generic clopidogrel–the medicines agency’s perspective

A number of generic products containing clopidogrel as the active substance have been marketed in Austria and the EU for some time. Due to different clopidogrel salt preparations and different indications, doubts arose a...

Maximizing quality in the manufacture of biologicals

Biological product quality is susceptible to unexpected manufacturing issues, and the resulting variation may impact the safety or efficacy of these medicines and increase risks to patients. These risks can be managed mo...

EORTC continues to support the appropriate treatment of adult patients with G-CSF to prevent febrile neutropenia: guideline updates

The European Organisation for Research and Treatment of Cancer (EORTC) has updated its 2006 guideline on the use of granulocyte colony-stimulating factor (G-CSF) for the prevention of febrile neutropenia (FN), a sometime...

What to look forward to in GaBI Journal, 2014, Issue 2

As mentioned previously, non-biological complex drugs (NBCDs) continue to raise important regulatory and practice issues. This issue of the GaBI Journal contains a number of manuscripts dealing with these products and be...

Download PDF file
  • EP ID EP355051
  • DOI 10.5639/gabij.2013.0202.024
  • Views 91
  • Downloads 0

How To Cite

Toshiki Sugita (2013). Recent trends and special topics in new drug review in PMDA. Generics and Biosimilars Initiative Journal, 2(2), 99-100. https://europub.co.uk./articles/-A-355051